News Feature | Published:

Vaccines for pandemics

Nature Biotechnology volume 31, pages 957960 (2013) | Download Citation

The 2009 H1N1 pandemic showed that the egg-based technology used to produce the bulk of flu vaccine is not nimble enough to protect during a pandemic. Charles Schmidt reports on progress in synthetic and recombinant technologies that may provide an answer.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Nat. Biotechnol. 28, 1227–1228 (2010).

  2. 2.

    et al. Sci. Transl. Med. 5, 185ra68 (2013).

  3. 3.

    et al. Nature 499, 102–106 (2013).

  4. 4.

    et al. Nat. Biotechnol. 30, 1210–1216 (2012).

  5. 5.

    et al. J. Virol. 87, 10435–10446 (2013).

  6. 6.

    et al. Sci. Transl. Med. 5, 200ra114 (2013).

Download references

Author information

Affiliations

  1. Portland, Maine

    • Charles Schmidt

Authors

  1. Search for Charles Schmidt in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.2733

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing